PHK
IMVT icon

Point72 Hong Kong’s Immunovant IMVT Stock Holding History

Point72 Hong Kong’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,416
Closed -$75.5K – 588
2025
Q1 		$75.5K Buy
+4,416
New +$92.4K ﹤0.01% 357
2022
Q4 		– Sell
-4,066
Closed -$23K – 839
2022
Q3 		$23K Buy
+4,066
New +$19.9K ﹤0.01% 1599
2022
Q2 		– Sell
-2,402
Closed -$13K – 2149
2022
Q1 		$13K Buy
2,402
+1,840
+327% +$11.5K ﹤0.01% 1571
2021
Q4 		$5K Buy
+562
New +$4.64K ﹤0.01% 1732
2021
Q1 		– Sell
-2,465
Closed -$114K – 1993
2020
Q4 		$114K Sell
2,465
-1,204
-33% -$55.7K 0.01% 1038
2020
Q3 		$129K Buy
+3,669
New +$110K 0.01% 516

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Point72 Hong Kong's IMVT Position: Q2 2025 in Review

Point72 Hong Kong sold out of Immunovant (IMVT) in Q2 2025, closing a stake of 4,416 shares — an estimated $75.5K sold.

Point72 Hong Kong first reported a position in IMVT in Q3 2020 and held it in 6 quarters. The position peaked at $129K in Q3 2020. 168 funds tracked by Wall St. Rank hold IMVT as of Q2 2025.

  • Point72 Hong Kong reported no remaining Immunovant position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 4,416 Immunovant shares in Q2 2025, an estimated $75.5K.
  • Point72 Hong Kong first reported a position in Immunovant in Q3 2020 and held it in 6 quarters.
  • Point72 Hong Kong's Immunovant position peaked at $129K in Q3 2020.
  • 168 funds tracked by Wall St. Rank held Immunovant as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.